Nebius stock slumps after guidance that revenue to come in low end of guidance
Nebius stock slumps after guidance that revenue to come in low end of guidance MarketWatch
Covered in this story
Analyst targets on Nebius Group
- Rosenblatt Securities: at $221 · target $304 by Oct 2027 · Buy via TIKR.com
- BNP Paribas Exane: at $243 · target $399 by Sep 2027 · Outperform via finance.yahoo.com
- Bank of America: at $278 · target $310 by Aug 2027 · Buy via Yahoo Finance
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $NBIS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nebius Group →Dalsna Finance is currently tracking 49 stories mentioning Nebius Group, the earliest published 1 Jul 2026.
Summary aggregated from MarketWatch's public RSS feed. The full reporting belongs to MarketWatch — please read it on their site.